Fundz

Galectin Therapeutics Inc reported raising in an initial SEC Form D filing

PUBLIC · GALTDec 21, 2015

Round Type

Venture

NorcrossBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

Galectin raised an undisclosed amount in a funding round, dated December 21, 2015. Galectin is based in Norcross, Georgia, United States.

How much did Galectin raise?
Galectin raised an undisclosed amount in a funding round on December 21, 2015.
What does Galectin do?
The NAVIGATE trial (NAVIGATEnash.com), entitled “A Seamless Adaptive Phase 2b/3, Double-Blind, Randomized, Placebo-controlled Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR-MD-02)..
Where is Galectin based and how big is it?
Galectin is based in Norcross, Georgia, United States. Fundz records about 15 employees.
Who are the decision-makers at Galectin?
Fundz holds 2 contacts at Galectin, including the Senior Director Project Management. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as Galectin that raised within 45 days of this round, from Fundz verified event records.

  • PharmaCyte Biotech, Inc. raised $1M (Seed) on January 19, 2016.
  • Apellis Pharmaceuticals raised $32M on January 6, 2016.
  • Q32 Bio raised $23M on January 6, 2016.
  • IRulya Therapeutics Inc. raised $7.9M on January 5, 2016.
  • ClearPoint Neuro raised $5.3M on December 21, 2015.
  • Verrica raised $2.4M on December 17, 2015.

Who to call at Galectin, and when

A new round usually means Galectin is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Galectin raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Galectin, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Galectin. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Galectin

Location

Norcross, Georgia, United States

About

The NAVIGATE trial (NAVIGATEnash.com), entitled “A Seamless Adaptive Phase 2b/3, Double-Blind, Randomized, Placebo-controlled Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR-MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis” began randomization of patients in August, 2020, and is posted on www.clinicaltrials.gov (NCT04365868). Galectin-3 has a significant role in cancer, and the Company has supported a Phase 1b study in combined immunotherapy of belapectin and KEYTRUDA in advanced melanoma and in head and neck cancer. This trial provided a strong rationale for moving forward into a Phase 2 development program which the company is considering.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Galectin raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsSharisse, Senior Director Project Management hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Galectin's next move

See what Strategic adds

Galectin raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.